Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03911661 · ClinicalTrials.gov registry record · NA
Fearon Algorithm in Warfarin Patient Self-Management
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03911661 is a NA study that has completed, run by University of Utah. The registered enrollment target is 30 participants.
The verdict
NCT03911661, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study aims to explore the feasibility of a novel, patient-specific algorithm for adjusting warfarin doses during chronic anticoagulation therapy. Specifically investigators are interested in determining whether patients can use this algorithm to assume responsibility for managing their own warfarin therapy including making independent decisions about their warfarin dose and when to retest their next international normalized ratio (INR) test based on the result of their current INR result obtained using a point-of-care INR monitor.
Interventions
- OTHER Usual care
- OTHER Fearon warfarin dosing algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-11-20 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03911661
The ClinicalTrials.gov registry entry for NCT03911661 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT03911661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03911661 about?
NCT03911661 is a clinical study titled "Fearon Algorithm in Warfarin Patient Self-Management". This study aims to explore the feasibility of a novel, patient-specific algorithm for adjusting warfarin doses during chronic anticoagulation therapy. Specifically investigators are interested in determining whether patients can use this algorithm to assume responsibility for managing their own warf...
What is the current status of trial NCT03911661?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-11-20. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03911661?
The interventions under investigation include: Usual care (OTHER), Fearon warfarin dosing algorithm (OTHER).
Who is sponsoring clinical trial NCT03911661?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.